Delivery Order HT942523D0011-HT942626FE033
Award Date 4/1/26
Potential Completion Date 3/31/27
Potential Value $270K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency has awarded a $927K firm fixed-price delivery order to Eitr Biologics, Inc., a San Diego-based biotechnology company specializing in antibody-based therapeutics and nanotherapeutics. The contract, awarded February 1, 2026, with an ultimate completion date of December 31, 2027, focuses on the development of novel bispecific broad-spectrum nanobodies intended to address biological threats. Performance will take place in San Diego, California. This delivery order carries...
- This is a $750,000.00 firm fixed price delivery order awarded by the Defense Health Agency (DHA) to Eitr Biologics, Inc. for the development of novel nanotherapeutic approaches for the treatment of pneumonic plague. The order is part of a larger $4.39 million Indefinite Delivery Vehicle (IDV) contract between Eitr Biologics and DHA to advance the research and development of nanotherapeutics to combat biological threats. The work will be performed in San Diego, California and involves assessing...
- The Defense Health Agency awarded a $1.3 million firm fixed-price purchase order to Eitr Biologics, Inc., a San Diego-based biotechnology company specializing in antibody discovery and viral countermeasures. The contract, set aside for small business, focuses on sorting peripheral blood mononuclear cells from Lassa fever virus survivors to discover and produce monoclonal antibodies for subsequent assessment in in vitro and in vivo assays. This work supports the Defense Health Agency's medical...
- The Office of the Assistant Secretary for Preparedness and Response awarded a $315.7 million definitive contract to Eitr Biologics, Inc. for development of a multimodal antibody platform to extend the window of immunotherapeutic intervention on September 22, 2023, under a cost-plus-fixed-fee structure with no set-aside. Place of performance is San Diego, CA 92121. The contract extends through September 30, 2034. The originating solicitation calls for critical evaluation of VHH (variable domain...
- The Defense Health Agency awarded a $110.5 million firm fixed-price delivery order to Mapp Biopharmaceutical, Inc., a San Diego-based biotechnology company specializing in antibody-based therapeutics and medical countermeasures. The delivery order, awarded on June 6, 2025, with completion scheduled for December 4, 2025, calls for the supply of monoclonal antibodies and viral recombinant antigens. No set-aside designation was used in this award. This delivery order is issued under Mapp's...
- The Defense Health Agency issued a delivery order to Inbios International Inc. on June 15, 2020, with a ceiling value of $25,655,995.03 for COVID-19 FDA EUA antigen detection and fast-track serology assay optimization under a Total Small Business set-aside. Inbios International Inc. is a minority-owned biotechnology company based in Seattle, Washington. Place of performance is Seattle, WA. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of May 31, 2025. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Evenity 210 mg dose in a two-syringe 1.17 mL configuration. The contract is valued at $11,111.59 and represents a firm fixed-price delivery order with an ultimate completion date of November 25, 2025. This award is not a set-aside contract and was competitively awarded through the System for Award Management. The place of performance is AmerisourceBergen's corporate...
- The Defense Health Agency issued a delivery order to General Dynamics Information Technology, Inc. on August 27, 2020, with a ceiling value of $21.1 million for drug development and experimental therapeutics research support at the Walter Reed Army Institute of Research. The delivery order is issued under OASIS, the General Services Administration's multiple-award indefinite delivery contract for IT, engineering, and professional services across federal agencies. Place of performance is Silver...
- <p>The Defense Health Agency issued a $2,500 delivery order to Battelle Memorial Institute on June 19, 2023, under the Omnibus IV Military Medical Research and Development IDIQ for military medical research and development services.</p> <p>Place of performance is Falls Church, VA. The order is firm fixed price with an ultimate completion date of June 19, 2023.</p>
- <p>The Defense Health Agency awarded a purchase order to Biocare Medical LLC for medical antibodies for laboratory use, with a ceiling value of $225,275.28 and an award date of March 25, 2024. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of March 24, 2027. No set-aside was used.</p>